Protalix BioTherapeutics Price to Free Cash Flow Ratio 2006-2019 | PLX

Historical price to free cash flow ratio values for Protalix BioTherapeutics (PLX) since 2006.
Protalix BioTherapeutics Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2019-10-22 0.24 0.00
2019-06-30 0.47 $-0.22 0.00
2019-03-31 0.44 $-0.26 0.00
2018-12-31 0.31 $-0.27 0.00
2018-09-30 0.73 $-0.30 0.00
2018-06-30 0.43 $-0.48 0.00
2018-03-31 0.54 $-0.45 0.00
2017-12-31 0.66 $-0.46 0.00
2017-09-30 0.58 $-0.70 0.00
2017-06-30 0.84 $-0.74 0.00
2017-03-31 1.36 $-0.87 0.00
2016-12-31 0.45 $-0.90 0.00
2016-09-30 0.57 $-0.83 0.00
2016-06-30 0.64 $-0.80 0.00
2016-03-31 0.84 $-0.71 0.00
2015-12-31 1.02 $-0.68 0.00
2015-09-30 1.18 $-0.75 0.00
2015-06-30 1.95 $-0.79 0.00
2015-03-31 1.78 $-0.83 0.00
2014-12-31 1.84 $-0.85 0.00
2014-09-30 2.42 $-0.88 0.00
2014-06-30 3.65 $-0.91 0.00
2014-03-31 4.58 $-0.95 0.00
2013-12-31 3.89 $-0.97 0.00
2013-09-30 4.53 $-0.63 0.00
2013-06-30 4.91 $-0.37 0.00
2013-03-31 5.49 $-0.10 0.00
2012-12-31 5.19 $-0.07 0.00
2012-09-30 5.18 $-0.40 0.00
2012-06-30 5.73 $-0.62 0.00
2012-03-31 6.37 $-0.83 0.00
2011-12-31 4.93 $-0.83 0.00
2011-09-30 4.60 $-1.06 0.00
2011-06-30 6.26 $-1.26 0.00
2011-03-31 6.08 $-1.44 0.00
2010-12-31 9.98 $-1.50 0.00
2010-09-30 8.69 $-0.43 0.00
2010-06-30 6.11 $-0.24 0.00
2010-03-31 6.56 $-0.09 0.00
2009-12-31 6.62 $-0.04 0.00
2009-09-30 8.26 $-0.79 0.00
2009-06-30 4.52 $-0.74 0.00
2009-03-31 2.00 $-0.69 0.00
2008-12-31 1.84 $-0.66 0.00
2008-09-30 2.23 $-0.59 0.00
2008-06-30 2.71 $-0.50 0.00
2008-03-31 2.63 $-0.46 0.00
2007-12-31 3.40 $-0.45 0.00
2007-09-30 34.56 $-0.46 0.00
2007-06-30 26.99 $-0.50 0.00
2007-03-31 31.32 $-0.55 0.00
2006-12-31 16.70 $-0.57 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.038B $0.034B
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx(R). Protalix's unique expression system presents a proprietary method for developing recombinant proteins in a cost-effective, industrial-scale manner. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the U.S. Food and Drug Administration (FDA) in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.697B 13.86
Gilead Sciences (GILD) United States $82.586B 10.14
CSL (CSLLY) Australia $78.316B 0.00
Celgene (CELG) United States $73.284B 11.34
Vertex Pharmaceuticals (VRTX) United States $47.174B 50.98
Illumina (ILMN) United States $46.133B 54.20
Biogen (BIIB) United States $41.226B 7.32
Regeneron Pharmaceuticals (REGN) United States $32.729B 14.85
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.586B 11.91
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.379B 0.00
Incyte (INCY) United States $16.902B 49.74
Seattle Genetics (SGEN) United States $16.316B 0.00
Genmab (GNMSF) Denmark $13.038B 73.13
BioMarin Pharmaceutical (BMRN) United States $12.279B 0.00
Exact Sciences (EXAS) United States $12.015B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.175B 54.54
Alnylam Pharmaceuticals (ALNY) United States $9.648B 0.00
Galapagos (GLPG) Belgium $8.635B 0.00
Bio-Techne Corp (TECH) United States $7.707B 53.24
Sarepta Therapeutics (SRPT) United States $6.439B 0.00
QIAGEN (QGEN) Netherlands $6.339B 20.82
BeiGene (BGNE) Cayman Islands $6.315B 0.00
Guardant Health (GH) United States $6.292B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.248B 0.00
Amarin (AMRN) Ireland $5.783B 0.00
Reata Pharmaceuticals (RETA) United States $5.478B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.165B 13.13
Moderna (MRNA) United States $5.118B 0.00
Exelixis (EXEL) United States $5.095B 13.24
Bluebird Bio (BLUE) United States $5.056B 0.00
Medicines (MDCO) United States $4.569B 0.00
China Biologic Products (CBPO) China $4.500B 28.09
ARGENX SE-ADR (ARGX) Netherlands $4.377B 0.00
Ascendis Pharma (ASND) Denmark $4.355B 0.00
Repligen (RGEN) United States $4.043B 78.46
Spark Therapeutics (ONCE) United States $3.880B 0.00
Blueprint Medicines (BPMC) United States $3.864B 0.00
MorphoSys AG (MOR) Germany $3.438B 0.00
Immunomedics (IMMU) United States $3.037B 0.00
Mirati Therapeutics (MRTX) United States $2.985B 0.00
Alkermes (ALKS) Ireland $2.893B 0.00
Emergent Biosolutions (EBS) United States $2.687B 40.36
Genmab (GMAB) Denmark $2.665B 0.00
MyoKardia (MYOK) United States $2.616B 0.00
Genomic Health (GHDX) United States $2.574B 48.28
Arena Pharmaceuticals (ARNA) United States $2.475B 5.32
Ultragenyx Pharmaceutical (RARE) United States $2.422B 0.00
Myriad Genetics (MYGN) United States $2.327B 24.25
Halozyme Therapeutics (HALO) United States $2.244B 0.00
Acceleron Pharma (XLRN) United States $2.241B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.218B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.189B 0.00
RA PHARMCTL INC (RARX) United States $2.174B 0.00
NeoGenomics (NEO) United States $2.111B 112.94
Amicus Therapeutics (FOLD) United States $2.108B 0.00
Ligand Pharmaceuticals (LGND) United States $2.064B 26.10
Cambrex (CBM) United States $2.005B 25.35
Zai Lab (ZLAB) China $1.908B 0.00
Akcea Therapeutics (AKCA) United States $1.762B 0.00
UniQure (QURE) Netherlands $1.643B 0.00
Insmed (INSM) United States $1.628B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.583B 0.00
Denali Therapeutics (DNLI) United States $1.454B 0.00
REGENXBIO (RGNX) United States $1.447B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.418B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.401B 0.00
Coherus BioSciences (CHRS) United States $1.338B 0.00
Zymeworks (ZYME) Canada $1.197B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.178B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.124B 0.00
Innoviva (INVA) United States $1.107B 3.20
Alector (ALEC) United States $1.033B 0.00
Editas Medicine (EDIT) United States $1.013B 0.00
AnaptysBio (ANAB) United States $0.993B 0.00
Sangamo Therapeutics (SGMO) United States $0.980B 0.00
Epizyme (EPZM) United States $0.978B 0.00
Fate Therapeutics (FATE) United States $0.950B 0.00
ANI Pharmaceuticals (ANIP) United States $0.918B 15.33
Achillion Pharmaceuticals (ACHN) United States $0.856B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Zealand Pharma (ZEAL) Denmark $0.845B 9.48
Codexis (CDXS) United States $0.793B 0.00
Twist Bioscience (TWST) United States $0.786B 0.00
Anika Therapeutics (ANIK) United States $0.785B 27.79
Cara Therapeutics (CARA) United States $0.778B 0.00
Principia Biopharma (PRNB) United States $0.752B 389.13
Athenex (ATNX) United States $0.742B 0.00
WAVE Life Sciences (WVE) Singapore $0.741B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.727B 26.23
Pharming Group (PHGUF) Netherlands $0.724B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Vericel (VCEL) United States $0.699B 0.00
Revance Therapeutics (RVNC) United States $0.691B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.673B 0.00
Cytokineticsorporated (CYTK) United States $0.667B 0.00
Heska (HSKA) United States $0.578B 74.86
Mesoblast (MESO) Australia $0.572B 0.00
MiMedx (MDXG) United States $0.564B 0.00
Intellia Therapeutics (NTLA) United States $0.555B 0.00
GENFIT S.A (GNFT) France $0.538B 0.00
Arvinas (ARVN) United States $0.537B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.511B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Retrophin (RTRX) United States $0.489B 0.00
BioDelivery Sciences (BDSI) United States $0.472B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
UROGEN PHARMA (URGN) United States $0.463B 0.00
Intra-Cellular Therapies (ITCI) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Adverum Biotechnologies (ADVM) United States $0.456B 0.00
DBV Technologies S.A (DBVT) France $0.450B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.450B 0.00
Cellectis S.A (CLLS) France $0.442B 0.00
Stemline Therapeutics (STML) United States $0.408B 0.00
Kadmon Holdings (KDMN) United States $0.401B 0.00
Bellus Health (BLU) Canada $0.396B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.389B 0.00
Arcus Biosciences (RCUS) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.378B 0.00
Agenus (AGEN) United States $0.352B 0.00
AC Immune SA (ACIU) Switzerland $0.351B 26.00
Lexicon Pharmaceuticals (LXRX) United States $0.351B 0.00
Precision BioSciences (DTIL) United States $0.334B 0.00
Prothena (PRTA) Ireland $0.333B 0.00
Kindred Biosciences (KIN) United States $0.320B 0.00
CytomX Therapeutics (CTMX) United States $0.320B 0.00
Protagonist Therapeutics (PTGX) United States $0.316B 0.00
Avid Bioservices (CDMO) United States $0.301B 0.00
Gritstone Oncology (GRTS) United States $0.296B 0.00
Pfenex (PFNX) United States $0.293B 0.00
Theratechnologies (THTX) Canada $0.291B 0.00
Starpharma Holdings (SPHRY) Australia $0.288B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.284B 0.00
ADMA Biologics Inc (ADMA) United States $0.283B 0.00
Geron (GERN) United States $0.279B 0.00
PDL BioPharma (PDLI) United States $0.279B 7.18
Dynavax Technologies (DVAX) United States $0.278B 0.00
Syros Pharmaceuticals (SYRS) United States $0.273B 0.00
Scholar Rock Holding (SRRK) United States $0.273B 0.00
Puma Biotechnology (PBYI) United States $0.270B 0.00
Cel-Sci (CVM) United States $0.266B 0.00
Sutro Biopharma (STRO) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.247B 368.33
MannKind (MNKD) United States $0.247B 0.00
OSMOTICA PHARM (OSMT) United States $0.244B 0.00
Seres Therapeutics (MCRB) United States $0.242B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.231B 0.00
Inovio Pharmaceuticals (INO) United States $0.230B 0.00
Albireo Pharma (ALBO) United States $0.229B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.225B 0.00
ChromaDex (CDXC) United States $0.217B 0.00
Athersys (ATHX) United States $0.209B 0.00
Kamada (KMDA) Israel $0.209B 7.98
Exicure (XCUR) United States $0.207B 0.00
Sorrento Therapeutics (SRNE) United States $0.207B 0.00
Compugen (CGEN) Israel $0.206B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.197B 0.00
Palatin Technologies (PTN) United States $0.191B 5.61
Clovis Oncology (CLVS) United States $0.188B 0.00
Affimed (AFMD) Germany $0.184B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.184B 0.00
Dyadic (DYAI) United States $0.179B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Prometic Life Sciences (PFSCF) Canada $0.174B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Senesco Technologies (ELOX) United States $0.157B 0.00
XOMA (XOMA) United States $0.157B 0.00
Arsanis (XFOR) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
BioTime (LCTX) United States $0.145B 9.70
Alcobra (ARCT) United States $0.141B 0.00
Cerecor (CERC) United States $0.141B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Emmaus Life Sciences (EMMA) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.125B 0.00
Menlo Therapeutics (MNLO) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.118B 0.00
Acorda Therapeutics (ACOR) United States $0.115B 0.00
Abeona Therapeutics (ABEO) United States $0.111B 0.00
NantKwest (NK) United States $0.109B 0.00
Novavax (NVAX) United States $0.106B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 4.31
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.104B 0.00
Aptinyx (APTX) United States $0.100B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
VBI Vaccines (VBIV) United States $0.096B 0.00
Antibe Therapeutics (ATBPF) Canada $0.094B 0.00
OvaScience (MLND) United States $0.094B 0.00
Celyad SA (CYAD) Belgium $0.092B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Trevena (TRVN) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Liquidia Technologies (LQDA) United States $0.085B 0.00
Verastem (VSTM) United States $0.084B 0.00
Vaccinex (VCNX) United States $0.082B 0.00
Mersana Therapeutics (MRSN) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
Aduro Biotech (ADRO) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.076B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Curis (CRIS) United States $0.068B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Selecta Biosciences (SELB) United States $0.064B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Orgenesis (ORGS) United States $0.058B 21.18
NewLink Genetics (NLNK) United States $0.056B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.054B 0.00
Applied Genetic Technologies (AGTC) United States $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.050B 0.00
Arbutus Biopharma (ABUS) Canada $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VIVUS (VVUS) United States $0.045B 0.00
Unum Therapeutics (UMRX) United States $0.043B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
Celsion (CLSN) United States $0.038B 0.00
Proteostasis Therapeutics (PTI) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.036B 0.00
Oncobiologics (OTLK) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
Aptevo Therapeutics (APVO) United States $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aytu Bioscience (AYTU) United States $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
TOCAGEN INC (TOCA) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Neuralstem (CUR) United States $0.003B 0.00